ArticleCancers2020

TERT Promoter Mutations Differently Correlate with the Clinical Outcome of MAPK Inhibitor-Treated Melanoma Patients.

Paola Del Bianco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.